ArticleBMC cancer2020

A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment.

Takashi Kawahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.